Psyence Biomedical
2 hedge funds and large institutions have $575K invested in Psyence Biomedical in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
13.15% more ownership
Funds ownership: 1.65% → 14.81% (+13%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less capital invested
Capital invested by funds: $718K → $575K (-$143K)
60% less funds holding
Funds holding: 5 → 2 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Parallel Advisors
San Francisco,
California
|
+$418K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$28K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.52K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$758 |
| 4 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Parallel Advisors
San Francisco,
California
| $575K | +$418K | +127,050 | +525% |
|
|
SFFS
2
Stonehage Fleming Financial Services
St. Helier,
Jersey
| $218 | -$3 | -1 | -1% |
|
|
VF
3
Virtu Financial
New York
| – | -$28K | -5,927 | Closed |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | -$2.52K | -535 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$758 | -161 | Closed |
|
PBM Hedge Fund Activity: Q1 2026 in Review
2 of the 8,142 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q1 2026, worth a combined $575K — down 20% from $718K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PBM and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Parallel Advisors, adding an estimated $418K. The largest seller was Virtu Financial, exiting entirely with an estimated $28K sold.
- 2 institutional investors held Psyence Biomedical (PBM) as of Q1 2026, down from 5 in Q4 2025.
- Funds reported $575K of Psyence Biomedical stock for Q1 2026, down 20% quarter-over-quarter.
- 0 funds opened new Psyence Biomedical positions in Q1 2026 and 3 closed out, a net change of -3 holders.
- The largest Psyence Biomedical buyer in Q1 2026 was Parallel Advisors, an estimated $418K added.
- The largest Psyence Biomedical seller in Q1 2026 was Virtu Financial, an estimated $28K sold.
Based on aggregated 13F filings for Q1 2026.